Navigation auf


Center for Molecular Cardiology

Clinical implications of GRACE 3.0


Women who develop a particular type of heart attack, ie non-ST segment elevation acute coronary syndrome (NSTE-ACS; accounting for roughly three quarters of heart attacks in females) are at high mortality risk. The GRACE score is the most established tool for risk assessment, yet provides lower predictive performance in women as compared to men, as comprehensively reported in the original article published by Florian A. Wenzl et al. in The Lancet

In a more recent report of the Swiss Medical Journal, Prof. Olivier Müller comments on clinical implications of the newly developed GRACE 3.0 score. Check out the full article, now available online.